IMU - Imugene Ltd.
Imugene tripled in price during 2003 and prices more or less remained at this level until early 2005. This was based on optimistic expectations which could not be met in the short term. There has been a fall and partial recovery in prices during 2005 (down 30% overall). The market cap of $22 million for the company is high and prices may fall further in 2006 without substantial commercialisation (down 8%). The recent positive trial results indicate that if these can be followed up, there may be some justification for current price levels and this has been supported by the recent licensing agreement with Merial. (10/2/06)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
-0.001(1.92%) |
Mkt cap ! $186.6M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.6¢ | 2.4¢ | $362.1K | 14.49M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 855562 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 4091106 | 19 |
View Market Depth
| Last trade - 15.29pm 29/04/2025 (20 minute delay) ? |
| IMU (ASX) Chart |